Bio-Path

(OTC) BPTH

Current Price$0.05

Market Cap$2.36M

Since IPO (2008)-100%

5 YearN/A

1 Year-73%

1 Month+25%

Bio-Path Financials at a Glance

Market Cap

$2.36M

Revenue (TTM)

$0.00

Net Income (TTM)

-$6.09M

EPS (TTM)

-$0.72

P/E Ratio

-0.06

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.05

Volume

4,616

Open

$0.05

Price

$0.05

Volume

4,616

Open

$0.05

Previous Close

$0.05

Daily Range

$0.04 - $0.05

52-Week Range

$0.01 - $0.17

Estimated Earnings Date

Aug 18, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.05

Volume

4,616

Open

$0.05

Previous Close

$0.05

Daily Range

$0.04 - $0.05

52-Week Range

$0.01 - $0.17

Estimated Earnings Date

Aug 18, 2026

BPTH News

3 Humongous Health-Care Stocks This Week

Keith SpeightsApr 13, 2014

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bio-Path

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Vikram Grover, CFA

Website

www.biopathholdings.com

Headquarters

Bellaire, TX 77401, US

BPTH Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

76.46%

Return on Capital

N/A

Return on Assets

-899.85%

Earnings Yield

-16.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.36M

Shares Outstanding

50.30M

Volume

4.62K

Avg. Volume

34.60K

Financials (TTM)

Gross Profit

-$75.00K

Operating Income

-$5.39M

EBITDA

-$5.67M

Operating Cash Flow

-$321.00K

Capital Expenditure

$0.00

Free Cash Flow

-$321.00K

Cash & ST Invst.

$12.00K

Total Debt

$511.00K

Bio-Path Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$11.00K

+65.6%

Gross Margin

0.00%

N/A

Market Cap

$2.36M

N/A

Market Cap/Employee

$236.40K

N/A

Employees

N/A

Net Income

-$270.00K

+90.5%

EBITDA

-$286.00K

+89.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$12.00K

-90.2%

Total Debt

$511.00K

+62.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$511.00K

+62.2%

Return on Assets

-9.00%

N/A

Return on Invested Capital

63.58%

N/A

Free Cash Flow

-$38.00K

+97.1%

Operating Cash Flow

-$38.00K

+97.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ELLXFElixinol Wellness Limited

ELLXFElixinol Wellness Limited$0.00-45.21%

EMMAEmmaus Life Sciences, Inc.

EMMAEmmaus Life Sciences, Inc.$0.01-7.26%

SQZBSQZ Biotechnologies Company

SQZBSQZ Biotechnologies Company$0.02+0.00%

HXBMHelix BioMedix, Inc.

HXBMHelix BioMedix, Inc.$1.79+0.00%

ORGSOrgenesis Inc.

ORGSOrgenesis Inc.$0.05-88.33%

PAIOFPaion AG

PAIOFPaion AG$0.01+0.00%

IDCNIndocan Resources Inc.

IDCNIndocan Resources Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

SOFISoFi Technologies

SOFISoFi Technologies$18.24-0.01%

Questions About BPTH

What is the current price of Bio-Path?

Bio-Path is trading at $0.05 per share.

What is the 52-week range for Bio-Path?

Over the past 52 weeks, Bio-Path has traded between $0.01 and $0.17.

How much debt does Bio-Path have?

As of the most recent reporting period, Bio-Path reported total debt of $511.00K.

How much cash does Bio-Path have on hand?

Bio-Path reported $12.00K in cash and cash equivalents in its most recent financial results.

What is Bio-Path’s dividend yield?

Bio-Path does not currently have a dividend yield.

Bio-Path

Bio-Path Financials at a Glance

BPTH News

3 Humongous Health-Care Stocks This Week

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bio-Path

BPTH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bio-Path Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BPTH

What is the current price of Bio-Path?

What is the 52-week range for Bio-Path?

How much debt does Bio-Path have?

How much cash does Bio-Path have on hand?

What is Bio-Path’s dividend yield?

Premium Investing Services